Fahad Salman1, Niels Bergsland1,2, Michael G Dwyer1,3, Bianca Weinstock-Guttman4, Robert Zivadinov1,3, and Ferdinand Schweser1,3
1Buffalo Neuroimaging Analysis Center, Department of Neurology at the Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, United States, 2IRCCS, Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy, 3Center for Biomedical Imaging, Clinical and Translational Science Institute, University at Buffalo, The State University of New York, Buffalo, NY, United States, 4Jacobs Multiple Sclerosis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, United States
1Buffalo Neuroimaging Analysis Center, Department of Neurology at the Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, United States, 2IRCCS, Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy, 3Center for Biomedical Imaging, Clinical and Translational Science Institute, University at Buffalo, The State University of New York, Buffalo, NY, United States, 4Jacobs Multiple Sclerosis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, United States
Over two years, both susceptibility and iron content decline significantly in the pulvinar of patients with multiple sclerosis.
Table 1. Intra-thalamic magnetic susceptibility (ppm) in patients and controls.
Table 2. Intra-thalamic iron content (mg) in patients and controls.